Proscia

Website

Proscia Inc.

21 Investors
Digital Pathology
PHILADELPHIA, PA

Proscia Inc. is an innovative software company specializing in digital and computational pathology solutions designed to modernize and expedite cancer diagnostics and research. By leveraging advanced technologies, Proscia empowers laboratories and medical professionals to enhance their pathology workflows and provide faster, more accurate diagnoses.

Products & Team

Concentriq

Pathology SoftwareSeed

Concentriq is Proscia's flagship enterprise pathology platform that facilitates the digitization of pathology workflows. It provides robust features for viewing, managing, analyzing, and sharing digital pathology images, enhancing the efficiency and accuracy of pathology processes.

Value Proposition

Concentriq addresses the urgent need for faster and more accurate cancer diagnostics by digitizing traditional workflows, thereby tackling the rising cancer burden and alleviating pathologist shortages.

Pain Points

Proscia addresses key challenges in the pathology field, including the need for better diagnostic accuracy, the increasing demand for timely cancer diagnoses, and the requirement for effective research and development in oncology.

Supports full digitization of clinical pathology workflowsOffers AI applications to assist pathologistsProvides a scalable platform suitable for various applicationsEnables streamlined collaboration among pathologists and researchers
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
PHILADELPHIA, PA
Primary headquarters

Funding History

Total Raised:
$35.0M
E

Equity, Option to Acquire Offering

Closed
March 2025
$35.0M
Raised
Progress
100%
Raised
$35.0M
Target
$35.0M
#000123191925000026